REGISTERED NUMBER: 07816557 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026

FOR

INTENSICHEM GROUP LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr O A A Tames

Mr J M Tiley

REGISTERED OFFICE:

1 Langley Court

Pyle Street

Newport

Isle of Wight

PO30 1LA

REGISTERED NUMBER:

07816557 (England and Wales)

ACCOUNTANTS:

Xeinadin Isle of Wight

1 Langley Court

Pyle Street

Newport

Isle of Wight

PO30 1LA

FIXED ASSETS

Intangible assets

4

70,114

84,499

Tangible assets

5

783

1,073

70,897

85,572

CURRENT ASSETS

Debtors

6

4,175

4,175

Cash at bank

1

1

4,176

4,176

CREDITORS

Amounts falling due within one year

7

-

62

NET CURRENT ASSETS

4,176

4,114

TOTAL ASSETS LESS CURRENT LIABILITIES

75,073

89,686

CAPITAL AND RESERVES

Called up share capital

8

35,594

35,594

Share premium

454,332

454,332

Retained earnings

(414,853

)

(400,240

)

SHAREHOLDERS' FUNDS

75,073

89,686

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 July 2026 and were signed on its behalf by:

Mr O A A Tames - Director

Mr J M Tiley - Director

1.	STATUTORY INFORMATION

Intensichem Group Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on reducing balance

Computer equipment

-

25% on reducing balance

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Patents and

licences

£

COST

At 1 February 2025

and 31 January 2026

150,661

AMORTISATION

At 1 February 2025

66,162

Amortisation for year

14,385

At 31 January 2026

80,547

NET BOOK VALUE

At 31 January 2026

70,114

At 31 January 2025

84,499

The intangible asset is the granted United Kingdom patent number 10960373, which relates to the invention of a continuous flow hydrogenation process and process apparatus. During February 2025 the company granted a licence to Intensichem Solutions Limited, a company controlled by Oliver Tames and John Tiley, allowing that company to use the said patent in return for a royalty of 30%, payable to the company, of the net sales value deriving from all patent exploitative products, sold or otherwise supplied for money or money's worth.

This licence replaced a similar agreement between the company and Intensichem Limited, a wholly owned subsidiary, which subsequent to the period end, during February 2025, entered into liquidation.

5.	TANGIBLE FIXED ASSETS

Plant and

Computer

machinery

equipment

Totals

£

£

£

COST

At 1 February 2025

and 31 January 2026

30,473

2,774

33,247

DEPRECIATION

At 1 February 2025

29,498

2,676

32,174

Charge for year

264

26

290

At 31 January 2026

29,762

2,702

32,464

NET BOOK VALUE

At 31 January 2026

711

72

783

At 31 January 2025

975

98

1,073

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Other debtors

4,175

4,175

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Other creditors

-

62

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

3,146

Ordinary A

£1

3,146

3,146

7,934

Ordinary B

£1

7,934

7,934

786

Ordinary C

£1

786

786

786

Ordinary D

£1

786

786

22,231

Ordinary E

£1

22,231

22,231

711

Ordinary F

£1

711

711

35,594

35,594

9.	ULTIMATE CONTROLLING PARTY

No individual is the ultimate controlling party. The shareholders among themselves hold the entire share capital of the company.